Brief: Nuvation Bio Q4 operating expenses USD 24.335 million
15/03/2023 22:27
Mar 15 (Reuters) - Nuvation Bio Q4 operating expenses USD 24.335 million. * Q4 net income USD -20.845 million * Q4 operating profit USD -24.335 million * Q4 pretax profit USD -20.845 million * Q4 EPS USD -0.1
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth